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Problem Identification
■ Nationally,  5 people die every hour 
from opioid overdose. 1
■ In 2017, 101 Vermonters died from 
opioid overdose* (16.2 fatalities per 
100,000 residents).   This rate 
increased 5% from the previous year, 
and has more than doubled since 
2010. 2
■ 12 of these deaths occurred in 
Washington County. 2
■ Preliminary data indicate 3 people died 
from opioid-related causes in 
Washington County in the first two 
months of 2018.  2
2a
*Defined as accidental or undetermined opioid-
related fatality (excludes suicides).
1. Centers for Disease Control (2018). Opioid Basics: Understanding the epidemic. 
2. Vermont Department of Health. (2018).  Opioid-Related Fatalities Among Vermonters.
From the Vermont Department of Health: Opioid-Related 
Fatalities Among Vermonters. 
Description of need
■ The Central Vermont Medical Center 
Community Health Needs Assessment 
for 2016 identified addressing drug 
abuse as a priority health need. 3
■ There were 1,361 EMS responses for 
potential overdose in Vermont in 2015. 4
■ Naloxone is an effective, low risk,  and 
easy to use reversal agent for opioid 
overdose.  95% of Vermonters who 
reported using naloxone for a potential 
overdose said that it reversed the 
overdose. 5
■ According to a recent survey of syringe 
exchange clients in Vermont, 68% were 
interested in potentially receiving more 
training on overdose reversal. 6
2b
3. Central Vermont Medical Center. (2016). Community Health Needs Assessment.
4. VanDonsel, et al. (2016).  Opioids in Vermont: Prevalence, Risk, and Impact.
5. Vermont Department of Health. (2018). Naloxone Distribution and Administration in Vermont- Data Brief.
6. Bakhtyari, et al. (2018). Barriers Encountered by Syringe Exchange Clients in VT.
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Data from the Vermont Department of Health: Opioid-
Related Fatalities Among Vermonters.
Public health cost
■ The opioid epidemic has cost 
the U.S. over a trillion dollars 
since 2001, with the majority of 
that cost coming from lost 
earnings and productivity due to 
overdose deaths. 7
■ The average cost to treat 
overdose patients admitted to 
hospital intensive care units is 
$92,408. 8
■ Naloxone distribution through 
syringe exchange services has 
been shown to provides good 
overall value for money 
invested. 9
3a
7.  Altarum.  (2018).  Economic Toll of Opioid Crisis in U.S. Exceeded $1 Trillion Since 2001.
8.  Stevens, J., et.al. (2017). Critical care crisis among opioid overdoses. 
9.  Uyei, J., et al.   Effects of naloxone distribution…..a cost-effectiveness modelling study. 
From Altarum: Economic Toll of Opioid Crisis in U.S. Exceeded $1 Trillion
Unique cost considerations in host community
■ The Vermont Department of Health provides 
naloxone kits to local organizations free of cost 
for distribution to at-risk Vermonters.
– The cost of a two-dose kit for the Department 
of Health is $75 *
■ In 2017 Vermont CARES distributed 240 naloxone 
kits and provided 15-30 minutes of individual 
client education for each kit given out. *    
– This amounts to a total of 60-120 hours of 
staff time spent on naloxone training.
■ Clients reported 40-55 overdose reversals 
attributed to the use of those kits. *
■ The cost per life saved is $325- $450 
3b
Moseley Covered Bridge in Northfield.  
Image by Jerrye & Roy Klotz, courtesy of Wikimedia commons. 
* P. Jacobsen, personal communication, June 5th, 2018)
Community Perspective on 
Issue and Support for Project
■ Regarding the education currently provided to clients when they receive a naloxone kit, Peter 
Jacobsen (executive director) explained that Vermont CARES staff provide a “thorough and 
thoughtful training including the steps in how to identify an overdose, what to do, how to administer 
the naloxone itself, and how to follow up with paramedics to ensure follow up care.” 
■ Theresa Vezina (assistant director) shared that, in addition to the in-person training  “…the 
Department of Health kit has an information handout with it, but few clients read it.  What we’d 
really like to incorporate next is a video on how to use naloxone that could be distributed, put on 
people’s phones, and shown to friends”.
■ Having a short video available would also give the option of pulling it up on a tablet and showing it 
to small groups of people, allowing questions and answers to be generated in a group environment, 
according to Mr. Jacobsen.
4
Vermont CARES is the largest and longest standing AIDS Service 
Organization in the state of Vermont. Available client services include 
substance abuse support, such as clean needles & safe injection supplies, 
mobile exchanges, free syringe disposal, overdose prevention education, 
overdose reversal kits (naloxone), and treatment option counseling10
10. Vermont Cares. (2018).  Vermont Cares Story. 
Intervention and Methodology
■ Syringe exchange clients were selected as the target 
for intervention as drug related fatalities involving 
heroin have increased in Vermont over the past 5 
years  (fatalities related to prescription opioids have 
been stable). 11
■ Vermont CARES community partners were 
interviewed and education surrounding naloxone was 
identified as a need in the local community.  
■ Specifically, a brief four to five minute video 
presentation was identified as a need to supplement 
existing education; currently education is provided in 
a 1:1 format and take-home materials are print only.
5a11. Vermont Department of Health.  (2017).  Opioid Misuse, Abuse, & Dependence in Vermont- Data Brief.
■ Existing training guidelines used by Vermont CARES for naloxone education were 
reviewed and the content which needed to be covered was noted.
■ Educational videos on naloxone use currently available online were found and viewed to 
determine if anything already in existence met this need.
Intervention and Methodology
■ Primary goals for the video:
– Easy to understand (grade 4-5 reading 
level per national recommendations for 
patient educational material)
– Comprehensive; should cover all 
educational content in existing training
– Engaging
– Format that would be easily accessible 
on phones
■ A draft of the video presentation and script 
was prepared and subsequently reviewed by 
the community partner for content, format, 
and any potentially biased language
■ The video presentation was created using 
VideoPad Video Editor®.  Audio was recorded 
and edited in Audacity® 2.2.2.   Final 
product was saved in mp4 file format.
5b
Results/Response
■ Vermont CARES will use the video as part of its naloxone training for clients.
■ Theresa Vezina : “I can’t tell you how much I absolutely love this video, and how helpful it is going 
to be for our clients and our staff!”
6
The final product was 
a four minute video 
covering the 
information provided 
in the existing 
Vermont CARES 
training on naloxone.
Evaluation of effectiveness 
Goal:  Video presentation is easy to understand.
Evaluation: Appropriate reading of level for script* confirmed via online Lexile analysis
*drug names were removed from script for analysis
Additional Proposed Evaluation:   
Assess client response to the following before and after viewing the video presentation:
Are you comfortable identifying the signs of and opioid overdose and administering naloxone if needed?  Yes/No
Goal:  Video covers all educational content in existing training.
Evaluation: Final product was compared to existing training material from Vermont CARES
and coverage of all content was verified.
Goal:  Video presentation is easily accessible on phones.
Evaluation:  Presentation was accessed without difficulty on both Android and iOS phones.
7a
Limitations 
■ Direct client perspective on the issue was 
difficult to obtain due to the inability to 
guarantee anonymity for interviewees.
■ Time limitations prevented a thorough 
assessment of client education gaps and 
preferences in educational materials prior to 
production.
■ Time and budget limitations affected the 
production quality of the video presentation.
■ Distribution through the Vermont CARES 
program primarily reaches individuals who 
use intravenous substances.  Vermonters at 
risk of overdose from oral or prescription 
opioids are less likely to benefit.  
7b
Recommendations for future interventions/projects
■ Consider uploading presentation to 
YouTube to reach a broader 
audience; assess any potential 
liability prior to doing so.
■ Vermont CARES currently provides 
fentanyl test kits and training in their 
use; another brief video could be 
created to provided education on 
this topic.
■ Contacting medical personnel is an 
important part of caring for 
someone suffering from a drug 
overdose; clients may be hesitant to 
do so for various reasons.  Vermont 
CARES has expressed interest in 
assessing if clients are reluctant to 
contact the paramedics and if so, 
why.  A qualitative survey could be 
created to address this question.
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